Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Journey Medical (DERM) Revenue: 2020-2024

Historic Revenue for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to $56.1 million.

  • Journey Medical's Revenue rose 20.52% to $17.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.4 million, marking a year-over-year increase of 2.82%. This contributed to the annual value of $56.1 million for FY2024, which is 29.11% down from last year.
  • Latest data reveals that Journey Medical reported Revenue of $56.1 million as of FY2024, which was down 29.11% from $79.2 million recorded in FY2023.
  • In the past 5 years, Journey Medical's Revenue registered a high of $79.2 million during FY2023, and its lowest value of $44.5 million during FY2020.
  • Its 3-year average for Revenue is $69.7 million, with a median of $73.7 million in 2022.
  • Its Revenue has fluctuated over the past 5 years, first skyrocketed by 41.78% in 2021, then fell by 29.11% in 2024.
  • Journey Medical's Revenue (MRY) stood at $44.5 million in 2020, then surged by 41.78% to $63.1 million in 2021, then increased by 16.69% to $73.7 million in 2022, then grew by 7.48% to $79.2 million in 2023, then dropped by 29.11% to $56.1 million in 2024.
  • Its last three reported values are $56.1 million in FY2024, $79.2 million for FY2023, and $73.7 million during FY2022.